Palatin Technologies, Inc. to Report Second Quarter, Fiscal Year 2021 Results; Teleconference and Webcast to be held on February 17, 2021
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Palatin Technologies (NYSE American: PTN) will announce its Q2 fiscal year 2021 operating results on February 17, 2021, before the U.S. financial markets open. A conference call will follow at 11:00 a.m. ET to discuss the results and provide updates on development programs. Interested parties can access the audio webcast through Palatin's website. The company focuses on developing targeted peptide therapeutics for significant unmet medical needs and seeks to establish collaborations to maximize the commercial potential of its products.
Details
News Market Reaction – PTN
The recorded move for PTN in the trading session of this news was -1.71%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
CRANBURY, N.J., Feb. 12, 2021 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN) will announce its second quarter, fiscal year 2021 operating results on Wednesday, February 17, 2021 before the open of the U.S. financial markets.
Palatin will also conduct a conference call and live audio webcast hosted by its executive management team on February 17, 2021 at 11:00 a.m. ET. The conference call will include a review of the company's operating results and an update on programs under development.
Schedule for the Operating Results Press Release, Conference Call / Audio Webcast
Q2 Fiscal Year 2021 Results Press Release | 2/17/2021 at 7:30 a.m. ET |
Q2 Fiscal Year 2021 Conference Call-Live | 2/17/2021 at 11:00 a.m. ET |
US/Canada Dial-In Number: | 1-866-248-8441 |
International Dial-In Number: | 1-856-344-9206 |
Conference ID: | 2203098 |
Q2 Fiscal Year 2021 Conference Call-Replay | 2/17/2021-2/24/2021 |
US/Canada Dial-In Number: | 1-888-203-1112 |
International Dial-In Number: | 1-719-457-0820 |
Replay Passcode: | 2203098 |
Audio Webcast Live and Replay Access |
The audio webcast and replay can be accessed by logging on to the "Investors-Webcasts" section of Palatin's website at http://www.palatin.com.
About Palatin Technologies, Inc.
Palatin Technologies, Inc. is a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential. Palatin's strategy is to develop products and then form marketing collaborations with industry leaders in order to maximize their commercial potential. For additional information, please visit http://www.palatin.com.
View original content to download multimedia:http://www.prnewswire.com/news-releases/palatin-technologies-inc-to-report-second-quarter-fiscal-year-2021-results-teleconference-and-webcast-to-be-held-on-february-17-2021-301227418.html
SOURCE Palatin Technologies, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.